ScreenerHero
MEDPMedpace Holdings, Inc.
NAS · US · Healthcare · Diagnostics & Research · medpace.com
609.17USD+0.15%Mkt Cap: 16.98B $P/E: 35.78

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, Asia, South America, Africa, and Australia. The company offers a suite of services supporting…

Industry Peers

Diagnostics & Research
Screen all
TMO
Thermo Fisher Scientific Inc.
$226.85BUSDP/E 33.1
DAP
Danaher Corporation
$142.58BUSDP/E 38.5
DHR
Danaher Corporation
$151.78BUSDP/E 38.6
LONN
Lonza Group Ltd
$46.70BUSDP/E 37.9
NTRA
Natera, Inc.
$46.86BUSD
IDXX
IDEXX Laboratories, Inc.
$44.35BUSDP/E 39.5
A
Agilent Technologies, Inc.
$44.14BUSDP/E 31.4
IQV
IQVIA Holdings Inc
$41.03BUSDP/E 31.0
WAT
Waters Corporation
$40.83BUSDP/E 105.8
ILU
Illumina, Inc.
$30.40BUSDP/E 40.4
ILMN
Illumina, Inc.
$30.95BUSDP/E 38.2
MTD
Mettler-Toledo International, Inc.
$28.55BUSDP/E 32.1
LH
Labcorp Holdings Inc.
$26.80BUSDP/E 27.4
DGX
Quest Diagnostics Incorporated
$26.68BUSDP/E 25.6
GH
Guardant Health, Inc.
$21.92BUSD
ERF
Eurofins Scientific SE
$13.65BUSDP/E 25.3
CRL
Charles River Laboratories International, Inc.
$13.84BUSD
RVTY
Revvity Inc. Common Stock
$13.33BUSDP/E 57.4
BIM
bioMérieux S.A.
$9.55BUSDP/E 19.1
QIA
Qiagen N.V.
$8.69BUSDP/E 22.8

Key Statistics

Company
Market Cap16.98B $
Enterprise Value16.74B $
Revenue (TTM)2.78B $
Gross Profit760.62M $
Net Income (TTM)451.12M $
Revenue/Share98.47 USD
Last Price609.17 USD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees6.5K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISINUS58506Q1094
Valuation
P/E (Trailing)35.78
P/E (Forward)31.73
PEG3.26
EV/EBITDA27.39
EV/Revenue6.02
P/S6.15
P/B39.41
EPS (TTM)17.16
EPS (Forward)19.31
52W Range
373.0077% of range677.90
52W High677.90 USD
52W Low373.00 USD
Profitability
Gross Margin30.06%
Oper. Margin20.76%
EBITDA Margin21.97%
Profit Margin17.83%
ROE98.27%
ROA22.84%
Growth
Revenue Growth17.20%
Earnings Growth37.10%
Cash Flow & Leverage
Operating CF713.22M $
CapEx (TTM)31.36M $
FCF Margin18.34%
FCF Yield3.01%
Net Debt-358.58M $
Net Debt/EBITDA-0.59
Balance Sheet
Debt/Equity0.25
Current Ratio0.73
Quick Ratio0.66
Book Value/Sh15.54 USD
Cash/Share18.01 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 USD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)581.83 USD
Upside (mean)-4.5%
Target Range370.00 USD – 692.00 USD
$370.00-4.5% to mean$692.00
# Analysts12
Ownership
Shares Out.27.91M
Float22.39M
Insiders19.71%
Institutions91.51%
Short Interest
Short Ratio4.5d
Short % Float7.81%
Short % Out.6.26%
Shares Short1.75M
Short (prev mo.)2.13M
Technical
SMA 50545.57 (+11.7%)
SMA 200520.24 (+17.1%)
Beta1.15
S&P 52W Chg18.16%
Avg Vol (30d)318.76K
Avg Vol (10d)193.09K
Technical Indicators
RSI (14)64.1
MACD16.6124
MACD Signal18.1958
MACD Hist.-1.5834
BB Upper621.84 USD
BB Middle585.93 USD
BB Lower550.02 USD
BB Width12.26%
ATR (14)19.54 USD
Vol Ratio (20d)0.46x